ActualEyes Inc. ^None

ActualEyes Inc. is a healthcare company that specializes in developing therapeutics and products for treating Fuchs' corneal endothelium dystrophy. Their products include eyedrops, regenerative cell-therapy based products, and therapeutics such as AE001 (phase I) and AE002. The company aims to provide hope to patients with vision impairments and achieve the implementation of new treatment methods in society.